CClinicalTrials.gg
Sign In
CompletedNCT05915403Updated Jun 23, 2023

Frequency of Sexual Intercourse,Women With Fibromyalgia

An observational study in Fibromyalgia, Pain and Depression, sponsored by Konya Beyhekim Training and Research Hospital. Completed at 1 site in Turkey. Open to female participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-06-23.

Sponsored by Konya Beyhekim Training and Research Hospital · Observational

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
200
Ages
18 Years to 55 Years
Sex
Female
01

Study summary

Does frequency of sexual intercourse affect symptom severity in female patients with fibromyalgia?

02

Conditions studied

  • Fibromyalgia
  • Pain
  • Depression
03

In context

Fibromyalgia

1,336 studies on the registry are indexed under Fibromyalgia; 266 are open to participants now.

This study's enrollment of 200 is above the median of 100 across 270 observational studies indexed under Fibromyalgia.

Browse Fibromyalgia studies →

Lead sponsor

Konya Beyhekim Training and Research Hospital is the lead sponsor of 31 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

tertiary healthcare facility

Inclusion criteria

* Female patient with fibromyalgia

Exclusion criteria

Exclusion Criteria:

  • Uncontrollable systemic disease (cardiovascular, pulmonary, hepatic, renal, hematological),
  • Major psychiatric disease,
  • Endocrine disease,
  • Pregnancy
  • Menopausal status,
  • Antihypertensive, antidepressant, anxiolytic, antiepileptic drugs use
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
200 participants (actual)
Patient registry
No

Groups and cohorts

  • Patient

    female patient with fibromyalgia

    Diagnostic Test: Fibromyalgia Impact Questionnaire

  • healthy controls

    women

Interventions

  • Diagnostic testFibromyalgia Impact Questionnaire

    diagnostic tests

    Also known as: Visual Analog Scale, Beck Depression Inventory, Widespread Pain Index, Symptom Severity Scale, frequency of sexual intercourse

06

What researchers measure

Primary outcomes

  1. Visual Analog Scale

    pain level 0-10, higher scores indicate worse outcome

    Time frame: 1 week

  2. frequency of sexual intercourse

    mean monthly frequency of sexual intercourse in the last 3 months

    Time frame: 3 mounths

  3. Fibromyalgia Impact Questionnaire

    0-80, higher scores indicate worse outcome

    Time frame: 1 week

Secondary outcomes

  1. Beck Depression Inventory

    0-63, higher scores indicate worse outcome

    Time frame: 1 week

  2. Widespread Pain Index

    0-19, higher scores indicate worse outcome

    Time frame: 1 week

  3. Symptom Severity Scale

    0-12, higher scores indicate worse outcome

    Time frame: 1 week

07

Study locations

1 site
  • Konya Beyhekim Research and Training Hospital
    Konya, Selçuklu 42060, Turkey
08

References and documents

Publications

  • Maunder L, Schoemaker D, Pruessner JC. Frequency of Penile-Vaginal Intercourse is Associated with Verbal Recognition Performance in Adult Women. Arch Sex Behav. 2017 Feb;46(2):441-453. doi: 10.1007/s10508-016-0890-4. Epub 2016 Nov 14. PubMed 27844312 ↗
  • Blaicher W, Gruber D, Bieglmayer C, Blaicher AM, Knogler W, Huber JC. The role of oxytocin in relation to female sexual arousal. Gynecol Obstet Invest. 1999;47(2):125-6. doi: 10.1159/000010075. PubMed 9949283 ↗
  • Burleson MH, Trevathan WR, Todd M. In the mood for love or vice versa? Exploring the relations among sexual activity, physical affection, affect, and stress in the daily lives of mid-aged women. Arch Sex Behav. 2007 Jun;36(3):357-68. doi: 10.1007/s10508-006-9071-1. PubMed 17109236 ↗
  • Ainsworth BE, Haskell WL, Herrmann SD, Meckes N, Bassett DR Jr, Tudor-Locke C, Greer JL, Vezina J, Whitt-Glover MC, Leon AS. 2011 Compendium of Physical Activities: a second update of codes and MET values. Med Sci Sports Exerc. 2011 Aug;43(8):1575-81. doi: 10.1249/MSS.0b013e31821ece12. PubMed 21681120 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 23, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05915403
Lead sponsor
Konya Beyhekim Training and Research Hospital
Responsible party
Savaş Karpuz (Medical doctor, Konya Beyhekim Training and Research Hospital) — Principal investigator
First posted
Jun 23, 2023
Start date
Dec 1, 2021
Primary completion
Dec 1, 2022
Completion
Feb 1, 2023
Last update
Jun 23, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Fibromyalgia→

Other studies from this sponsor

Konya Beyhekim Training and Research Hospital

Start the discussion